Risk Factors for Upstaging, Recurrence, and Mortality in Clinical T1-2 Renal Cell Carcinoma Patients Upstaged to pT3a Disease: An International Analysis Utilizing the 8th Edition of the Tumor-Node-Metastasis Staging Criteria.

Published on Apr 1, 2020in Urology1.924
· DOI :10.1016/J.UROLOGY.2019.11.036
Zachary Hamilton9
Estimated H-index: 9
(UCSD: University of California, San Diego),
Umberto Capitanio62
Estimated H-index: 62
+ 15 AuthorsIthaar H. Derweesh43
Estimated H-index: 43
(UCSD: University of California, San Diego)
Sources
Abstract
Abstract OBJECTIVE To investigate risk factors for and outcomes in pathological T3a-upstaging in Renal Cell Carcinoma (RCC), as Tumor-Node-Metastasis staging for T3a RCC was recently revised. METHODS Multicenter retrospective analysis of patients with clinical T1-T2 RCC, stratified by occurrence of pathologic T3a-upstaging. Primary outcome was recurrence-free survival (RFS). Multivariable analyses (MVA) were conducted for upstaging and recurrence. Kaplan−Meier analysis (KMA) was utilized for RFS and overall survival (OS). RESULTS We analyzed 2573 patients (1223 RN/1350 PN). Upstaging occurred in 360 (14.0%). On MVA, higher clinical stage was associated with increasing risk of upstaging [cT1a (referent), OR for cT1b, cT2a and cT2b was 2.6, 6.5, and 14.1, p CONCLUSIONS Risk of pT3a-upstaging and recurrence in pT3a-upstaged RCC correlates with clinical stage at presentation. Renal vein and perinephric fat invasion were associated with increased risk of recurrence. PN did not increase risk of recurrence and potential of pT3a-upstaging should not deter consideration of PN.
📖 Papers frequently viewed together
5 Authors (Luyao Chen, ..., Bin Fu)
3 Citations
20161.92Urology
40 Citations
7 Citations
References30
Newest
#1Börje Ljungberg (Umeå University)H-Index: 70
#2Laurance Albiges (Université Paris-Saclay)H-Index: 1
Last. Axel Bex (Royal Free London NHS Foundation Trust)H-Index: 54
view all 19 authors...
Abstract Context The European Association of Urology Renal Cell Carcinoma (RCC) Guideline Panel has prepared evidence-based guidelines and recommendations for the management of RCC. Objective To provide an updated RCC guideline based on standardised methodology including systematic reviews, which is robust, transparent, reproducible, and reliable. Evidence acquisition For the 2019 update, evidence synthesis was undertaken based on a comprehensive and structured literature assessment for new and ...
434 CitationsSource
#1Benjamin T. Ristau (Fox Chase Cancer Center)H-Index: 12
#2Elizabeth Handorf (Fox Chase Cancer Center)H-Index: 25
Last. Marc C. Smaldone (Fox Chase Cancer Center)H-Index: 34
view all 6 authors...
BACKGROUND: Partial nephrectomy (PN) is recommended for localized T1a (≤4 cm) renal masses and is preferred over radical nephrectomy (RN) for amenable T1b/T2 (>4 cm) tumors. The objective of the current study was to assess overall survival (OS) differences between PN and RN in patients with T1 and T2 renal cell carcinoma (RCC). METHODS: The National Cancer Data Base was queried for patients with T1 and T2 RCC who underwent PN or RN from 2004 to 2014. Trends in surgery were evaluated using Cochra...
21 CitationsSource
#1Ithaar H. Derweesh (UCSD: University of California, San Diego)H-Index: 43
#2Stephen Ryan (UCSD: University of California, San Diego)H-Index: 8
Last. Zachary Hamilton (UCSD: University of California, San Diego)H-Index: 9
view all 3 authors...
8 CitationsSource
#1Steven C. Campbell (American Urological Association)H-Index: 71
#2Robert G. Uzzo (American Urological Association)H-Index: 18
Last. Bradley C. Leibovich (American Urological Association)H-Index: 89
view all 15 authors...
Purpose: This AUA Guideline focuses on evaluation/counseling and management of adult patients with clinically localized renal masses suspicious for cancer, including solid-enhancing tumors and Bosniak 3/4 complex-cystic lesions.Materials and Methods: Systematic review utilized research from the Agency for Healthcare Research and Quality and additional supplementation by the authors and consultant methodologists. Evidence-based statements were based on body of evidence strength Grade A/B/C (Stron...
603 CitationsSource
#1Cheuk Fan Shum (IU: Indiana University)H-Index: 5
#2Clinton D. Bahler (IU: Indiana University)H-Index: 15
Last. Chandru P. Sundaram (IU: Indiana University)H-Index: 44
view all 3 authors...
Abstract Objectives: To compare overall survival (OS) and immediate postoperative outcomes between partial and radical nephrectomy (RN) for T2 N0 M0 tumors and identify significant factors for poor OS. Patients and Methods: Using the National Cancer Database, we identified patients with T2 N0 M0 renal cancer between 2004 and 2009 who were treated with partial or radical nephrectomy. The partial and RN groups were statistically matched by demographics and tumor characteristics. We used Cox multip...
12 CitationsSource
#1Paras Shah (Smith Institute)H-Index: 10
#2Daniel M. Moreira (UIC: University of Illinois at Chicago)H-Index: 32
Last. Louis R. Kavoussi (Smith Institute)H-Index: 109
view all 13 authors...
Purpose: We studied recurrence-free survival after partial vs radical nephrectomy for clinical stage T1 renal cell carcinoma in all patients and in those up staged to pathological stage T3a.Materials and Methods: We retrospectively reviewed the records of 1,250 patients who underwent partial or radical nephrectomy for clinically localized T1 renal cell carcinoma between 2006 and 2014. Recurrence-free survival was estimated using the Kaplan-Meier method and evaluated as a function of nephrectomy ...
36 CitationsSource
#1Simon P. Kim (Yale University)H-Index: 39
#2Steven C. Campbell (Cleveland Clinic)H-Index: 71
Last. Alexander Kutikov (Fox Chase Cancer Center)H-Index: 52
view all 8 authors...
Abstract Background While partial nephrectomy (PN) is the recommended treatment for many small renal masses, anatomically complex tumors necessitate a clear understanding of the potential risks and benefits of PN and radical nephrectomy (RN). Objective To critically review the comparative effectiveness evidence of PN versus RN; to describe key trade-offs involved in this treatment decision; and to highlight gaps in the current literature. Evidence acquisition A collaborative critical review of t...
58 CitationsSource
#1Steffen LebentrauH-Index: 8
#2Sven RauterH-Index: 1
Last. Martin SchostakH-Index: 29
view all 7 authors...
Introduction If technically feasible, organ-preservation is indicated for T1 renal cell carcinoma (RCC), since partial nephrectomy (PN) is equivalent to radical nephrectomy with regard to tumor-specific survival and probably achieves better overall survival. Treatment results of a training clinic were assessed with regard to guideline adherence and treatment quality.
2 CitationsSource
#1Maria Carmen MirH-Index: 19
#2Ithaar H. Derweesh (UC San Diego Health System)H-Index: 43
Last. Riccardo Autorino (Case Western Reserve University)H-Index: 68
view all 6 authors...
Abstract Background Partial nephrectomy (PN) is the reference standard of management for a cT1a renal mass. However, its role in the management of larger tumors (cT1b and cT2) is still under scrutiny. Objective To conduct a meta-analysis assessing functional, oncologic, and perioperative outcomes of PN and radical nephrectomy (RN) in the specific case of larger renal tumors (≥cT1b). The primary endpoint was an overall analysis of cT1b and cT2 masses. The secondary endpoint was a sensitivity anal...
172 CitationsSource
#1Pascal Mouracade (Cleveland Clinic)H-Index: 7
#2Onder Kara (Cleveland Clinic)H-Index: 13
Last. Jihad H. Kaouk (Cleveland Clinic)H-Index: 98
view all 7 authors...
Objectives To evaluate perioperative morbidity, oncological outcome and predictors of pT3a upstaging after partial nephrectomy (PN).
27 CitationsSource
Cited By8
Newest
Objectives We aimed to determine preoperative risk factors associated with pathologic T3a (pT3a) upstaging of clinical T1 (cT1) renal cell carcinomas (RCCs) and develop a novel model capable of accurately identifying those patients at high risk of harboring occult pT3a characteristics. Methods A retrospective analysis of 1324 cT1 RCC patients who underwent partial nephrectomy (PN) or radical nephrectomy (RN) was performed. The study cohort was divided into training and testing datasets in a 70:3...
1 CitationsSource
#1Luigi Nocera (UdeM: Université de Montréal)H-Index: 5
#2Lara Franziska Stolzenbach (UdeM: Université de Montréal)H-Index: 4
Last. Alberto BrigantiH-Index: 96
view all 17 authors...
We hypothesized that pT3a stage at nephrectomy can be accurately predicted in cT1N0M0 clear cell-renal cell carcinoma (cc-RCC) patients. Of 236 patients, treated with either partial or radical nephrectomy (2005-2019), 25 (10.6%) harbored pT3a stage. Multivariable logistic regression models predicting pT3a were fitted using age, tumor size, tumor location and exophytic rate. The new model was 81% accurate. In calibration plots, minimal departures from ideal prediction were recorded. In decision c...
2 CitationsSource
The OBJECTIVE was to analyze the developmental trends, possibilities and outcomes of applying minimally invasive technologies in surgical treatment for kidney cancer. METHODS AnD MATERIALS. The study included 368 surgeries for kidney tumors which were performed from 2012 to 2019. Partial nephrectomy (Pn) was performed in 228 (60.6 %) cases, radical nephrectomy (Rn) – in 148 (39.4 %) cases. Tumors of the stage cT1a detected in 148 (39.4 %), сТ1b – 145 (38.6 %), сT2a – 58 (15.4 %), сТ2b-cTxn1M1 – ...
Source
#1Brittney Cotta (UCSD: University of California, San Diego)H-Index: 7
#2Margaret Meagher (UCSD: University of California, San Diego)H-Index: 5
Last. Ithaar H. Derweesh (UCSD: University of California, San Diego)H-Index: 43
view all 16 authors...
OBJECTIVE To investigate association of pre-treatment C-Reactive Protein (CRP) and non-cancer mortality (NCM) in a cohort of patients undergoing surgery for localized renal cell carcinoma (RCC). METHODS Retrospective multicenter analysis of patients surgically treated for clinical stages 1-2 RCC from 2006-17, excluding all cases of cancer-specific mortality. Descriptive analyses were obtained between normal pre-treatment CRP (≤0.5mg/dL) and elevated CRP (>0.5mg/dL) groups. Primary outcome was NC...
3 CitationsSource
#1Hui LiuH-Index: 1
#2Qing-Fang KongH-Index: 1
Last. Ming ChenH-Index: 18
view all 8 authors...
Background Kidney cancer is the most common malignant tumor of the kidney in adults. However, in terms of the treatment for pT3a renal cell carcinoma (RCC), whether partial nephrectomy (PN) can be selected is still controversial. This study was conducted to compare the efficacy of PN and radical nephrectomy (RN) in treatment for patients with pT3a RCC. Methods The relative English databases including PubMed and EMBASE were searched for studies comparing PN and RN for pT3a RCC between 2010 and 20...
Source
#1Kendrick Yim (UCSD: University of California, San Diego)H-Index: 7
#2Monish Aron (SC: University of Southern California)H-Index: 67
Last. Ithaar H. Derweesh (UCSD: University of California, San Diego)H-Index: 43
view all 27 authors...
Abstract Background Use of partial nephrectomy (PN) in T3 renal cell carcinoma (RCC) is controversial. Objective To evaluate quality outcomes of robot-assisted PN (RAPN) for clinical T3a renal masses (cT3aRM). Design, setting, and participants This was a retrospective multicenter analysis of patients with cT3aN0M0 RCC who underwent RAPN. Intervention RAPN. Outcome measurements and statistical analysis The primary endpoint was a trifecta composite outcome of negative surgical margins, warm ischem...
1 CitationsSource
#1Aaron Bradshaw (UCSD: University of California, San Diego)H-Index: 5
#2Riccardo AutorinoH-Index: 68
Last. Ithaar H. Derweesh (UCSD: University of California, San Diego)H-Index: 43
view all 30 authors...
OBJECTIVE: To compare outcomes of minimally invasive radical nephrectomy (MIS-RN) and robotic-assisted partial nephrectomy (RAPN) in clinical T2a renal mass (T2aRM). METHODS: Retrospective, multicenter, propensity score-matched (PSM) comparison of RAPN and MIS-RN for T2aRM (T2aN0M0). Cohorts were PSM for age, sex, BMI, ASA Class, clinical tumor size, and RENAL score using 2:1 ratio for RN:PN. Primary outcome was disease-free survival (DFS). Secondary outcomes included overall survival (OS), comp...
17 CitationsSource